ERCC3 Gene Associated with Breast Cancer: A Genetic and Bioinformatic Study
The Breast Journal · 2024
DOI: 10.1155/2024/7278636 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Breast Journal, 2024. Verfasst von Xiangyu Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology Changsha Hospital for Maternal and Child Health Care Hunan Normal University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Breast Neoplasms, DNA-Binding Proteins, Computational Biology, Genetic Predisposition to Disease. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Female breast cancer is the most common and the fifth deadliest cancer worldwide. It is influenced by a combination of genetic, hormonal, and environmental factors. The excision repair cross‐complementation group 3 gene ( ERCC3 ) has recently been identified as a breast cancer susceptibility gene in various cohorts of different geographical and ethnic origin. To explore the role of ERCC3 mutations in breast cancer development and pathological diagnosis, genetic analysis was conducted in 291 patients and 291 controls from mainland China. Bioinformatic analysis and immunohistochemistry (IHC) were performed. A novel ERCC3 mutation p.Y116X was identified in a breast cancer family, while no frequency bias for the genotype and allele of rs754010782 and rs371627165 was observed (all P > 0.05). Bioinformatic analysis revealed that ERCC3 expression was negatively associated with estrogen receptor (ER), progesterone receptor (PR), nontriple‐negative status, and nodal status of breast cancers. ERCC3 amplifications and deep deletions primarily occurred in breast invasive cancer not otherwise specified (NOS) and metaplastic breast cancer, respectively. The decreased ERCC3 expression in tumor tissues of patient with p.Y116X mutation was found by IHC. The ERCC 3 mutation p.Y116X may increase breast cancer risk in the Han‐Chinese population. ERCC3 exhibits potential as a biomarker for the pathological diagnosis of breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology Changsha Hospital for Maternal and Child Health Care Hunan Normal University, Changsha, Hunan, China.
- Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control Changsha Hospital for Maternal and Child Care Hunan Normal University, Changsha, Hunan, China.
- Department of Pathology School of Medicine Hunan Normal University, Changsha, Hunan, China.
ORCID-Profile: Xiangyu Chen, Heng Xiao, Shuangcheng Ning, Bang Liu, Huashan Zhou, Ting Fu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Chen, X., Xiao, H., Ning, S., Liu, B., Zhou, H., & Fu, T. (2024). ERCC3 Gene Associated with Breast Cancer: A Genetic and Bioinformatic Study. The Breast Journal. https://doi.org/10.1155/2024/7278636
Vancouver
Chen X, Xiao H, Ning S, Liu B, Zhou H, Fu T. ERCC3 Gene Associated with Breast Cancer: A Genetic and Bioinformatic Study. The Breast Journal. 2024. doi:10.1155/2024/7278636
BibTeX
@article{Chen2024,
author = {Chen, Xiangyu and Xiao, Heng and Ning, Shuangcheng and Liu, Bang and Zhou, Huashan and Fu, Ting},
title = {ERCC3 Gene Associated with Breast Cancer: A Genetic and Bioinformatic Study},
journal = {The Breast Journal},
year = {2024},
doi = {10.1155/2024/7278636}
}
EUVIMED